CAMBRIDGE TRUST CO - EDITAS MEDICINE INC ownership

EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 255 filers reported holding EDITAS MEDICINE INC in Q2 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
CAMBRIDGE TRUST CO ownership history of EDITAS MEDICINE INC
ValueSharesWeighting
Q2 2023$8,230
+13.5%
1,0000.0%0.00%
Q1 2023$7,250
+80455.6%
1,0000.0%0.00%
Q4 2022$9
-99.9%
1,0000.0%0.00%
-100.0%
Q3 2022$12,0000.0%1,0000.0%0.00%0.0%
Q2 2022$12,000
-36.8%
1,0000.0%0.00%0.0%
Q1 2022$19,000
-29.6%
1,0000.0%0.00%0.0%
Q4 2021$27,0001,0000.00%
Other shareholders
EDITAS MEDICINE INC shareholders Q2 2022
NameSharesValueWeighting ↓
CloudAlpha Capital Management Limited/Hong Kong 645,000$36,532,0004.39%
DDD Partners, LLC 320,391$18,147,0002.76%
NIA IMPACT ADVISORS, LLC 70,364$3,985,0001.94%
Sassicaia Capital Advisers LLC 29,386$1,664,0001.74%
CloudAlpha Capital Management Limited/Hong Kong 221,000$12,517,0001.50%
Elmwood Wealth Management, Inc. 40,023$2,267,0001.20%
Green Alpha Advisors, LLC 30,925$1,752,0001.19%
Nikko Asset Management Americas, Inc. 4,869,696$285,684,0001.12%
Lombard Odier Asset Management (Switzerland) SA 303,133$17,169,0000.87%
Spectrum Planning & Advisory Services Inc. 15,784$894,0000.86%
View complete list of EDITAS MEDICINE INC shareholders